Company insider dossier

Humana Inc insider intelligence

HUM filings assessed for conviction, transaction quality, insider breadth, clustering, freshness, and price confirmation.

Terminal chart Weekly report Factor intelligence Healthcare Healthcare Plans Data API
50/100

No directional read

35/100 confidence
Exchange
NYSE
Sector
Healthcare
Industry
Healthcare Plans
Latest evidence
1 Sep 2026

Investment committee read

No directional read

The tape contains filings, but none provide enough priced common-share evidence for a directional classification.

Evidence is contextual

Evidence in favour

  • Participation spans 14 named insiders rather than one filing source.

Decision risks

  • Most filings are awards, derivatives, unpriced common shares, or other securities and remain contextual.
Conviction50No directional read
Confidence35Thin evidence
Named insiders14participating in the tape
Controlled events0directional common-share events
Acquisition value$187.2Knormalized amount
Disposal value$70.4Knormalized amount

Price confirmation map

Weekly price with common-share events

Acquisitions and disposals are aligned to the nearest completed weekly bar.

409.80348.49287.18225.88164.57
Mar 2025Sep 2026
Weekly closeCommon-share acquisitionCommon-share disposal

Market confirmation

Price and trend context

Latest close
386.22 USD
One-week move
-5.8%
Four-week move
+1.9%
Fair-value gap
+25.4%
Trend signal
Active
Relative strength
27.5

Directional balance

Controlled event mix

0%acquisition
Acquisition events
0
Disposal events
0
Net value
$116.9K

Cadence

Twelve-week filing pressure

Volume shows attention. Controlled events determine direction.

006 Jul
013 Jul
020 Jul
227 Jul
003 Aug
010 Aug
017 Aug
024 Aug
131 Aug
007 Sep
014 Sep
021 Sep

Named participants

Insider conviction by person

HILZINGER, KURT JDirector500 events
RENAUDIN, GEORGE IIPresident, Insurance500 events
SHETTY, SANJAY KPresident, CenterWell500 events
CRAWFORD, FREDERICK JOHNDirector500 events
DINTENFASS, DAVIDPresident, Enterprise Growth500 events
FIELD, ROBERT STUARTDirector500 events
MARTIN, AARONPresident, Medicare Advantage500 events
MEHTA, JAPANChief Information Officer500 events
MELLET, CELESTEChief Financial Officer500 events
NUNDY, SHANTANUChief Medical Officer500 events
O'HARA, MICHELLE A.Chief Human Resources Officer500 events
RECHTIN, JAMES A.President & CEO500 events

Evidence quality

Security and transaction context

Common equity0
Equity compensation3
Options and derivatives0
Other securities14

Role architecture

Who is participating

Other executive10
Director5
CEO and chair1
Finance leadership1

Transaction evidence

Auditable HUM filing ledger

Showing 1 to 17 of 17.

NUNDY, SHANTANUChief Medical Officer
AcquisitionOther securities
2549 sharesHumana Common
Not reportedContext evidence
CRAWFORD, FREDERICK JOHNDirector
AcquisitionOther securities
544 sharesHumana Common
Not reportedContext evidence
SMITH, PAUL JOHNDirector
AcquisitionOther securities
544 sharesHumana Common
Not reportedContext evidence
HILZINGER, KURT JDirector
AcquisitionEquity compensation
233 sharesRestricted Stock Units
$91.4KContext evidence
DINTENFASS, DAVIDPresident, Enterprise Growth
AcquisitionOther securities
11273 sharesHumana Common
Not reportedContext evidence
FIELD, ROBERT STUARTDirector
AcquisitionOther securities
852 sharesHumana Common
Not reportedContext evidence
MARTIN, AARONPresident, Medicare Advantage
AcquisitionOther securities
8206 sharesHumana Common
Not reportedContext evidence
MEHTA, JAPANChief Information Officer
AcquisitionOther securities
9448 sharesHumana Common
Not reportedContext evidence
MELLET, CELESTEChief Financial Officer
DisposalOther securities
15387 sharesHumana Common
Not reportedContext evidence
O'HARA, MICHELLE A.Chief Human Resources Officer
AcquisitionOther securities
10485 sharesHumana Common
Not reportedContext evidence
RECHTIN, JAMES A.President & CEO
AcquisitionOther securities
35633 sharesHumana Common
Not reportedContext evidence
SHETTY, SANJAY KPresident, CenterWell
AcquisitionOther securities
9945 sharesHumana Common
Not reportedContext evidence
VENTURA, JOSEPH CChief Legal Officer
AcquisitionOther securities
10318 sharesHumana Common
Not reportedContext evidence
SHETTY, SANJAY KPresident, CenterWell
AcquisitionOther securities
887 sharesHumana Common
Not reportedContext evidence
SHETTY, SANJAY KPresident, CenterWell
DisposalOther securities
401 sharesHumana Common
$70.4KContext evidence
HILZINGER, KURT JDirector
AcquisitionEquity compensation
536 sharesRestricted Stock Units
$91.5KContext evidence
RENAUDIN, GEORGE IIPresident, Insurance
AcquisitionEquity compensation
25 sharesPhantom Stock Units
$4.3KContext evidence

Reading the dossier

Direction and confidence are separate

Conviction

The 0 to 100 score classifies deduplicated priced common-share evidence. Fifty is balanced or non-directional.

Confidence

Confidence rises with controlled event depth, named-insider breadth, fresh evidence, normalized values, and a longer observation span.

Disposals

Selling is not treated as the mirror image of buying. It carries less directional weight because taxes, diversification, compensation, and planned transactions can all create sales.

Price confirmation

The market chart tests whether the filing thesis is being confirmed or rejected by price, fair-value position, relative strength, and the current trend state.

Independent market research for education. This classification is not investment advice, a recommendation, a forecast, or an execution instruction.

Evidence context